LAMIVUDINE and ZIDOVUDINE 150 mg/1 (LAMIVUDINE and ZIDOVUDINE TABLET, FILM COATED) 150 mg/1

LAMIVUDINE and ZIDOVUDINE 150 mg/1 tablets are a combination medication used in the management of HIV infection. This oral treatment helps control the virus and improve quality of life.

Strength

150 mg/1

Pack Size

500 TABLET, FILM COATED in 1 BOTTLE (31722-506-05)

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

LAMIVUDINE and ZIDOVUDINE 150 mg/1 tablets are primarily used in the treatment of HIV infection. This combination therapy works by reducing the amount of HIV in the body, which helps the immune system function better. It is often prescribed as part of a broader antiretroviral regimen to manage the virus and improve overall health. The medication is designed to be taken orally and is intended for long-term use under medical supervision.

Side Effects

Common effects of LAMIVUDINE and ZIDOVUDINE 150 mg/1 tablets may include nausea, fatigue, and headache. Some individuals might experience changes in body fat distribution or mild gastrointestinal discomfort. These effects can vary from person to person and may subside over time as the body adjusts to the medication.

Precautions & Warnings

LAMIVUDINE and ZIDOVUDINE 150 mg/1 tablets should be handled with care and stored as directed. It is important to follow the prescribed dosage and not to share the medication with others. Regular medical check-ups are recommended to monitor the effectiveness and any potential side effects of the treatment.

Avoid Interactions

LAMIVUDINE and ZIDOVUDINE 150 mg/1 tablets may interact with other medications, including certain antiretrovirals, antibiotics, and medications that affect liver enzymes. Alcohol consumption should be avoided as it can exacerbate side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

LAMIVUDINE and ZIDOVUDINE 150 mg/1 tablets are used in the management of HIV infection as part of a combination therapy.

These tablets are taken orally, typically as prescribed by a healthcare provider. Always follow the dosage instructions provided.

Common side effects may include nausea, fatigue, and headache. Some individuals might also experience changes in body fat distribution.

It is important to consult a healthcare provider before taking LAMIVUDINE and ZIDOVUDINE with other medications to avoid potential interactions.

Store the tablets at room temperature, away from moisture and heat, and keep them out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.